Medicine and Health Sciences Commons^™

Implementing A Prescreening Process To Fully Assess Risk Factors And Outcomes Associated With Obesity And Hepatic Steatosis To Prevent Cirrhosis, Shana Broussard, Jennifer Eaglebarger

Doctoral Projects

Fatty liver disease can be treated if is identified in the initial stages of the disease. Once the disease progresses to fibrosis and/or cirrhosis, there is irreversible damage. The leading cause of non-alcoholic fatty liver disease is obesity. Obesity has reached epidemic proportions, with most obese individuals not fully cognizant of the repercussions of prolonged obesity. Other risk factors for fatty liver disease are uncontrolled diabetes mellitus, hyperlipidemia, and hypertension. Certain medications can also increase the risk of fatty liver disease. Currently, there is no prescreening tool to identify patients who are at risk for fatty liver disease. The researchers …